SN
Sushree Nivedita Sarangi
About Sushree Nivedita Sarangi
Data last updated:
Sushree Nivedita Sarangi is a Designated Partner at Globevanta Asia Exports Llp (since 2025), Designated Partner at Meta Igentico Llp (since 2025) and Designated Partner at Daksun Clinical Research Llp (since 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Globevanta Asia Exports Llp ACR-7218 | Designated Partner | 29 Sep 2025 | 2025 | Active | |
| Meta Igentico Llp ACR-5091 | Designated Partner | 19 Sep 2025 | 2025 | Active | |
| Daksun Clinical Research Llp ACI-1105 | Designated Partner | 07 Apr 2025 | 2024 | Active |
Board colleagues of Sushree Nivedita Sarangi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Priyambada Swain | 11321175 | Globevanta Asia Exports Llp | Designated Partner |
| Rakshith Sundar | 07497793 | Globevanta Asia Exports Llp , Daksun Clinical Research Llp | Designated Partner |
| Rekha Suchchal | 11307647 | Meta Igentico Llp | Designated Partner |
| Sundar Rajath | 10689950 | Daksun Clinical Research Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sushree Nivedita Sarangi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sushree Nivedita Sarangi
Sushree Nivedita Sarangi currently holds 3 directorships: Globevanta Asia Exports Llp (Designated Partner, since 29 Sep 2025); Meta Igentico Llp (Designated Partner, since 19 Sep 2025); Daksun Clinical Research Llp (Designated Partner, since 07 Apr 2025).
Sushree Nivedita Sarangi was first appointed on 07 Apr 2025 as Designated Partner at Daksun Clinical Research Llp.
The current boards of Sushree Nivedita Sarangi's companies include Priyambada Swain (Globevanta Asia Exports Llp), Rakshith Sundar (Globevanta Asia Exports Llp), Rekha Suchchal (Meta Igentico Llp), Sundar Rajath (Daksun Clinical Research Llp).